11.16 (-%)
As of Nov 20, 2024
Source:
Cybin Inc. is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.
| Country | United States |
| Headquarters | toronto |
| Phone Number | (908) 764-8385 |
| Industry | |
| CEO | Douglas Drysdale |
| Website | cybin.com |